What Are Tumors?

Tumors are abnormal masses of tissue that result from the uncontrolled proliferation of cells that have lost their normal regulatory mechanisms governing growth and division. They are classified as benign, in which cells remain localized and do not invade surrounding tissue, or malignant, in which cells acquire the ability to invade adjacent structures and spread to distant sites through the bloodstream or lymphatic system. Malignant tumors constitute cancer, a category of disease that accounts for a substantial fraction of global mortality. The engineering and biomedical research communities have invested heavily in improving tools for tumor detection, characterization, and treatment, bringing contributions from signal processing, medical imaging, machine learning, and radiation physics.

Tumor Biology and Classification

Tumor development proceeds through a series of genetic and epigenetic alterations that disrupt normal cell cycle checkpoints, apoptosis pathways, and DNA repair mechanisms. The process, called oncogenesis, typically requires the accumulation of mutations in both oncogenes, which promote growth, and tumor suppressor genes, which normally restrain it. Tumors are further classified by the tissue of origin: carcinomas arise from epithelial cells, sarcomas from connective tissue, lymphomas and leukemias from blood-forming cells, and gliomas from glial cells of the nervous system. Each histological type carries distinct genetic signatures, growth patterns, and responses to therapy, which is why accurate classification is a prerequisite for treatment planning. The National Cancer Institute's database of cancer genomics research documents the molecular profiles of these subtypes in detail, supporting the development of targeted therapies matched to specific mutation signatures.

Imaging and Detection

Non-invasive imaging is the primary means of tumor localization, staging, and treatment monitoring. Computed tomography (CT) and magnetic resonance imaging (MRI) provide structural information about tumor size, location, and relationship to adjacent structures. Positron emission tomography (PET), which measures the metabolic activity of tissue by detecting gamma rays produced by a positron-emitting radiotracer such as fluorodeoxyglucose (FDG-18), exploits the elevated glucose consumption of rapidly dividing cells to distinguish metabolically active tumor tissue from healthy tissue. PET is particularly valuable for staging, detecting recurrence, and assessing treatment response when structural changes lag behind metabolic ones. Combined PET/CT and PET/MRI scanners provide both metabolic and anatomical information in a single scan session. Deep learning methods have demonstrated strong performance on tumor segmentation and detection tasks across multiple modalities, as reviewed in IEEE Xplore publications on brain tumor detection and classification, with convolutional neural networks now routinely assisting radiologists in identifying lesions in brain, breast, and lung imaging studies.

Bioelectrical Properties and Emerging Sensing

Tumor tissues differ from normal tissues in electrical conductivity and impedance, a consequence of altered cell membrane permeability, increased cell density, and changes in extracellular ion concentrations. These differences have motivated development of electrical impedance tomography and magnetoacoustic tomography approaches that reconstruct conductivity maps of tissue, providing a functional complement to structural imaging. Research published in PMC on high-frequency magnetoacoustic tomography demonstrates spatial resolutions on the order of 1 mm in animal models, suggesting potential for early detection of breast cancer where conductivity contrast is pronounced. Microwave imaging and thermoacoustic methods offer additional modalities under investigation for low-cost, radiation-free screening.

Applications

Tumors are a central subject of research and clinical engineering in a wide range of fields, including:

• Radiation oncology, where treatment planning systems calculate dose distributions to maximize tumor irradiation while sparing healthy tissue
• Surgical robotics, where image-guided systems assist in tumor resection with millimeter precision
• Drug delivery engineering, where nanoparticle carriers are designed to accumulate preferentially in tumor vasculature
• Biomarker discovery, where liquid biopsy techniques detect circulating tumor DNA in blood samples
• Medical imaging hardware development, where improved PET detector arrays and MRI coil designs increase sensitivity for small lesions